- 2 Resultados
precio mínimo: € 109,00, precio máximo: € 173,95, precio promedio: € 141,48
1
Pedir
por Indigo.ca
(aprox. € 173,95)
PedirEnlace patrocinado

Cancer Pharmacogenetics - libro nuevo

ISBN: 9780387691336

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the internation… Más…

Gastos de envío:más gastos de envío
2
Pedir
por bol.com
€ 109,00
PedirEnlace patrocinado

Springer-Verlag New York Inc.:

Cancer Pharmacogenetics - libro nuevo

2008, ISBN: 9780387691336

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the internation… Más…

  - Nieuw, Vermoedelijk 4-6 weken Gastos de envío:Vermoedelijk 4-6 weken, más gastos de envío bol.com

1Dado que algunas plataformas no nos comunican las condiciones de envío y éstas pueden depender del país de entrega, del precio de compra, del peso y tamaño del artículo, de una posible membresía a la plataforma, de una entrega directa por parte de la plataforma o a través de un tercero (Marketplace), etc., es posible que los gastos de envío indicados por eurolibro/terralibro no concuerden con los de la plataforma ofertante.

Datos bibliográficos del mejor libro coincidente

Detalles del libro

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the international HapMap project. Cancer therapy offers an ideal scenario for the integration of pharmacogenetics into clinical practice - often there are multiple treatment options but a finite window of time to select the correct one. The ideal of testing patients for genetic markers for chemotherapy efficacy and/or toxicity is becoming a reality with FDA approved clinical tests and genotype-guided clinical trials. This volume is designed to offer an overview of the role of pharmacogenetics in cancer treatment, from the history of the field through to its integration into clinical practice. TOC:A History of Pharmacogenetics.- Pharmacokinetics and pharmacogenetics.- drug targets and pharmacogenetics.- Pharmacodynamics and pharmacogenetics.- toxicity and pharmacogentics.- Leukemia: the TPMT Example.- Solid tumors I: The UGT1A1 Example.- Solid Tumors II: the EGFR Example.- Novel Pharmacogenetic markers: whole genome association studies.- In silico resources for cancer pharmacogenetics: databases and knowledge bases.- pharmacogenetics methodology-overview of available methods.- From bedside to clinical practice I: Clinical trials.- From Bedside to Clinical Practice II: FDA.- The Future of Cancer Pharmacogenetics

Detalles del libro - Cancer Pharmacogenetics


EAN (ISBN-13): 9780387691336
ISBN (ISBN-10): 0387691332
Año de publicación: 2008
Editorial: Springer

Libro en la base de datos desde 2008-03-03T01:33:19-06:00 (Mexico City)
Página de detalles modificada por última vez el 2017-02-01T14:28:53-06:00 (Mexico City)
ISBN/EAN: 9780387691336

ISBN - escritura alterna:
0-387-69133-2, 978-0-387-69133-6
Mode alterno de escritura y términos de búsqueda relacionados:
Título del libro: pharmacogenetics, cancer


Datos del la editorial

Autor: Sharon Marsh
Título: Cancer Pharmacogenetics
Editorial: Springer; Springer US
280 Páginas
Año de publicación: 2010-06-15
New York; NY; US
Idioma: Inglés
112,30 € (DE)
115,45 € (AT)
150,65 CHF (CH)
Not available, publisher indicates OP

BB; Book; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; cancer therapy; genetics; chemotherapy; toxicity; cancer treatment; drug; leukemia; pharmacodynamics; research; pharmacokinetics; clinical trial; cancer; kinetics; B; Cancer Research; Biomedical and Life Sciences; Pharmacology/Toxicology; Health Promotion and Disease Prevention; Epidemiology; Medical Microbiology; Pharmakologie; Public Health und Präventivmedizin; Epidemiologie und medizinische Statistik; Mikrobiologie und Virologie; EA

A History of Pharmacogenetics.- Pharmacokinetics and pharmacogenetics.- drug targets and pharmacogenetics.- Pharmacodynamics and pharmacogenetics.- toxicity and pharmacogentics.- Leukemia: the TPMT Example.- Solid tumors I: The UGT1A1 Example.- Solid Tumors II: the EGFR Example.- Novel Pharmacogenetic markers: whole genome association studies.- In silico resources for cancer pharmacogenetics: databases and knowledge bases.- pharmacogenetics methodology-overview of available methods.- From bedside to clinical practice I: Clinical trials.- From Bedside to Clinical Practice II: FDA.- The Future of Cancer Pharmacogenetics
This volume is designed to offer an overview of the role of pharmacogenetics in cancer treatment, from the history of the field through to its integration into clinical practice.

< para archivar...